Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04893811
What this trial is testing

Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age

Who this might be right for
Meningococcal Vaccine
Pfizer 53
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Study completedNCT05075824
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Hoffmann-La Roche 95
Not applicableUnknownNCT03535220
What this trial is testing

The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease

Who this might be right for
Benign and Malignant Hematologic Diseases
American Society of Hematology 20,000
Not applicableStudy completedNCT04526405
What this trial is testing

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases

Who this might be right for
Thalassemia MajorCovid19
University of Milano Bicocca 63
Post-approval studies (Phase 4)Study completedNCT00171301
What this trial is testing

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Who this might be right for
Beta-thalassemia MajorHemosiderosisIron Overload+1 more
Novartis Pharmaceuticals 233
Testing effectiveness (Phase 2)Ended earlyNCT02947100
What this trial is testing

Omega-3 Fatty Acids in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Robin E. Miller 4
Not applicableUnknownNCT03275051
What this trial is testing

Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)

Who this might be right for
Beta Thalassaemia
IRCCS San Raffaele 9
Not applicableActive Not RecruitingNCT06875219
What this trial is testing

To Evaluate Long- Term Safety and Efficacy of Luspatercept

Who this might be right for
Thalassemia Major
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia 350
Not applicableUnknownNCT05475223
What this trial is testing

End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis

Who this might be right for
End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the NewbornNeonatal JaundiceEnd Tidal Carbon Monoxide
Cedars-Sinai Medical Center 350
Large-scale testing (Phase 3)WithdrawnNCT04293172
What this trial is testing

Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.

Who this might be right for
Sickle Cell Disease
AstraZeneca
Not applicableEnded earlyNCT02887118
What this trial is testing

Dense Red Blood Cells in Sickle Cell Children

Who this might be right for
Sickle Cell Disease
Centre Hospitalier Intercommunal Creteil 82
Testing effectiveness (Phase 2)Study completedNCT00745420
What this trial is testing

Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)

Who this might be right for
Sickle Cell Disease
Medical College of Wisconsin 30
Not applicableStudy completedNCT03293641
What this trial is testing

Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya

Who this might be right for
Sickle Cell DiseaseZinc DeficiencyInfection
Lucas Otieno Tina, MD MSc 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04610866
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

Who this might be right for
Sickle Cell DiseaseHemolytic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Ended earlyNCT05445128
What this trial is testing

Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Ensoma 1
Not applicableStudy completedNCT04080167
What this trial is testing

Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 382
Not applicableStudy completedNCT01206075
What this trial is testing

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

Who this might be right for
Beta-Thalassemia
University of Washington 20
Not applicableLooking for participantsNCT05842109
What this trial is testing

Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN

Who this might be right for
ABO Hemolytic Disease of Newborn
Women's Hospital School Of Medicine Zhejiang University 112
Large-scale testing (Phase 3)Ended earlyNCT00310830
What this trial is testing

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Actelion 14
Next Page